Pr. Yair Reisner from the Weizmann Institute of Science, Head of Tissera Sponsored Research Team, Has Been Invited to Speak at the Annual Congress of the British Transplantation Society.

Herzliya, March 27, 2007

Tissera Inc. (OTCBB:TSSR - News) reports that Pr. Yair Reisner, head of the research team at the Weizmann Institute of Science sponsored by the company, has been invited by the British Transplantation Society to speak at the Stem Cell Symposium on Friday 30th March.

The Symposium will be part of the annual congress of the British Transplantation Society, meeting at the International Conference Centre in Manchester 28th-30th March 2007.

Pr. Reisner will give a state of the art lecture on "Embryonic pig precursor tissue as a new source for organ transplantation", which is the principal subject of the research work carried by him and his team for Tissera.

About Tissera
Tissera is a biotechnology company dedicated to the development of novel tissue precursor regeneration technologies for treating gene deficiencies and diseases in which organ transplantation is necessary, while minimizing the dosage of immunosuppressive drugs. Tissera obtained the license for the worldwide exclusive rights to the technology developed by Professor Yair Reisner and his team at the Weizmann Institute of Science in Israel. In this research, scientists successfully implanted in mice embryonic human and porcine organ precursor tissues, which grew into functional organs. This research was published in Nature Medicine and attracted worldwide scientific and media attention.

CONTACT:

Tissera Inc.

(Investor Relations)            

Dr. Uri Elmaleh  

uri@tissera.com

+972-52-5716669

SOURCE:  Tissera, Inc.